Catheter-related bladder discomfort
Conditions
Interventions
blank control group:Intravenous injection of 4ml normal saline following psychological comfort
Acupoint Normal Saline Group:Bilateral Zusanli acupoint injection of 2ml normal saline per acupoint (total 4ml) following psychological comfort
Acupoint Tramadol Group:Bilateral Zusanli acupoint injection of tramadol (1.5mg/kg) diluted to 4ml with normal saline, 2ml per acupoint
Intravenous Tramadol Group:Intravenous tramadol (1.5mg/kg) diluted to 4ml with normal saline following psychological comfort
Sponsors
West China Second University Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: ASA physical status I-II, age >18 years, elective gynecological surgery patients with intraoperative catheterization reporting moderate-to-severe CRBD.
Exclusion criteria
Exclusion criteria: Tramadol allergy, neuropsychiatric disorders, cognitive dysfunction, infection or surgical scars at acupoint sites, pathological bladder conditions, urinary obstruction, urinary tract infection, overactive bladder, neurogenic bladder, intraoperative urinary tract or intestinal injury, severe hepatic/renal dysfunction, chronic pain patients using long-term opioids, communication barriers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRBD severity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score;Postoperative nausea and vomiting;Comfort level;Additional analgesic/antiemetic use;Satisfaction; | — |
Countries
China
Contacts
Public ContactGu Juan
West China Second University Hospital, Sichuan University
Outcome results
None listed